RECRUITING

Rutgers University Study of the Genetics of Breast Cancer.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to learn more about how genes impact the risk of breast cancer. Anyone 18 or older living in the US is eligible, and a diagnosis of cancer is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.

Official Title

The Rutgers University Genetics Coordinating Center Breast Cancer Study

Quick Facts

Study Start:2024-04-15
Study Completion:2027-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06773897

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * age 18 years or older
  2. * currently living in the United States
  3. * able to understand and follow written instructions in English
  4. * have access to the internet and a computer, laptop, tablet or smart phone
  5. * willing to provide written informed consent for participation
  6. * willing to provide DNA via a saliva sample using a collection kit mailed to your home
  7. * willing to complete a survey with questions about health related to the study of breast cancer.
  1. * Not able to meet or fulfill any of the inclusion criteria

Contacts and Locations

Study Contact

Tara Matise, Ph.D.
CONTACT
848-445-3125
rugcc@rutgers.edu
Steve Buyske, Ph.D.
CONTACT
848-445-7680
rugcc@rutgers.edu

Principal Investigator

Tara Matise, Ph.D.
PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersey

Study Locations (Sites)

Rutgers University
Piscataway, New Jersey, 08854
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

  • Tara Matise, Ph.D., PRINCIPAL_INVESTIGATOR, Rutgers, The State University of New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-15
Study Completion Date2027-04-30

Study Record Updates

Study Start Date2024-04-15
Study Completion Date2027-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer Risk
  • Breast Cancer Prevention
  • Breast Cancer